SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-19-000012
Filing Date
2019-02-12
Accepted
2019-02-12 17:17:52
Documents
6
Period of Report
2019-01-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k021219.htm 8-K 42579
2 exhibit_10.htm EX-10 26133
3 exhibit_99-1.htm EX-99.1 49951
4 exhibit_99-2.htm EX-99.2 9505
5 image00006.jpg GRAPHIC 6758
6 image00009.jpg GRAPHIC 87986
  Complete submission text file 0001367644-19-000012.txt   260051
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 19592042
SIC: 2834 Pharmaceutical Preparations